The Aggressive Cholesterol Therapy to Inhibit Vein Graft Events trial: To continue or not? How to answer the question

J Thorac Cardiovasc Surg. 2019 Jan;157(1):164-165. doi: 10.1016/j.jtcvs.2018.09.066. Epub 2018 Oct 9.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Cholesterol
  • Coronary Artery Bypass
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors*

Substances

  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Cholesterol